Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)

[1]  G. Giaccone,et al.  Thymic epithelial tumors: From biology to treatment. , 2020, Cancer treatment reviews.

[2]  James R. Anderson,et al.  Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study. , 2019, The Lancet. Oncology.

[3]  J. Larkin,et al.  Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial. , 2018, The Lancet. Oncology.

[4]  G. Giaccone,et al.  Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study. , 2018, The Lancet. Oncology.

[5]  Benjamin J. Raphael,et al.  The Integrated Genomic Landscape of Thymic Epithelial Tumors. , 2018, Cancer cell.

[6]  Yi-Song Wang,et al.  Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors. , 2017, Cancer research.

[7]  Ananda L Roy,et al.  Pathophysiology of TFII-I: Old Guard Wearing New Hats. , 2017, Trends in molecular medicine.

[8]  Yi-Song Wang,et al.  PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  V. Lennon,et al.  Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma. , 2016, JAMA neurology.

[10]  Y. J. Kim,et al.  High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry , 2016, Nature Genetics.

[11]  R. Marks,et al.  Modified Masaoka Stage and Size Are Independent Prognostic Predictors in Thymoma and Modified Masaoka Stage Is Superior to Histopathologic Classifications , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  A. Nicholson,et al.  The Impact of Thymoma Histotype on Prognosis in a Worldwide Database , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  P. Meltzer,et al.  Mutations of epigenetic regulatory genes are common in thymic carcinomas , 2014, Scientific Reports.

[14]  J. Crowley,et al.  The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  A. Chella,et al.  Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  P. Meltzer,et al.  Copy Number Aberrations of Genes Regulating Normal Thymus Development in Thymic Epithelial Tumors , 2013, Clinical Cancer Research.

[17]  Lang Li,et al.  Molecular Analysis of Thymoma , 2012, PloS one.

[18]  G. Giaccone,et al.  Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  P. Meltzer,et al.  Expression and Mutational Status of c-kit in Thymic Epithelial Tumors , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  N. Girard,et al.  Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas , 2009, Clinical Cancer Research.

[21]  P. Kangueane.  Bioinformation Discovery: Data to Knowledge in Biology , 2009 .

[22]  H. Ohmatsu,et al.  Mutational status of EGFR and KIT in thymoma and thymic carcinoma. , 2008, Lung cancer.

[23]  M. Raica,et al.  Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus. , 2008, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[24]  R. Pfeiffer,et al.  Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies , 2003, International journal of cancer.

[25]  B. Barak,et al.  Neurobiology of social behavior abnormalities in autism and Williams syndrome. , 2016, Nature neuroscience.

[26]  P. Kangueane.  Major Histocompatibility Complex (MHC) and Peptide Binding , 2009 .